We are offering a wide range of anti cancer injection which is procured from reliable sources across the globe. Our range is supplied in bulk to the leading chemist shops and hospitals across the globe. We pay paramount attention towards the quality of our range and make sure that these anti cancer capsules are packed in proper packing material.
Daxid (50 mg) - Sertraline- Tablet is manufactured by Pfizer Limited (Pharmacia India Pvt Ltd) and the main constituent generic drug is Sertraline- 50 mg.Side EffectsDry mouth, nausea, stomach upset, diarrhoea, tremor, sweating, dizziness, sleeplessness, indigestion, paraesthesia, decreased libido, rash, hot flushes, blurred vision.IndicationsDepression.Obsessive compulsive disorder.Panic disorder.Premenstrual dysphoric disorder.
|Acamprol - Acamprol is a drug used for treating alcohol dependence.|
Acamprol is thought to stabilize the chemical balance in the brain that would otherwise be disrupted by alcoholism, possibly by blocking glutamatergic N-methyl-D-aspartate receptors, while gamma-aminobutyric acid (GABA) type A receptors are activated. Reports indicate that Acamprol only works with a combination of attending support groups and abstinence from alcohol. Certain serious side effects include allergic reactions, irregular heartbeats, and low or high blood pressure, while less serious side effects include headaches, insomnia, and impotence. Acamprosate should not be taken by people with kidney problems or allergies to the drug.
Indications: Alcohol deaddiction.
|Active ingredients: Acamprosate|
Syndopa - Syndopa (L-dopa) is used to replace dopamine lost in Parkinson's disease because dopamine itself cannot cross the blood-brain barrier where its precursor can. However, L-DOPA is converted to dopamine in the periphery as well as in the CNS, so it is administered with a peripheral DDC (dopamine decarboxylase) inhibitor such as carbidopa, without which 90% is metabolised in the gut wall, and with a COMT inhibitor if possible; this prevents about a 5% loss. The form given therapeutically is therefore a prodrug which avoids decarboxylation in the stomach and periphery, can cross the blood-brain barrier, and once in the brain is converted to the neurotransmitter dopamine by the enzyme aromatic-L-amino-acid decarboxylase.
Indication: For the treatment of idiopathic Parkinson's disease (Paralysis Agitans), postencephalitic parkinsonism, symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication, and manganese intoxication.
Levodopa is converted to a chemical called dopamine (DOE pa meen) in the brain. Symptoms of Parkinson's disease may be caused by low levels dopamine in the brain. Levodopa is turned into dopamine in the body.
Syndopa helps prevent the breakdown of levodopa before it can reach the brain and take effect.
The combination of Syndopa and levodopa is used to treat Parkinson symptoms such as muscle stiffness, tremors, spasms, and poor muscle control.
Syndopa and levodopa is also used to treat Parkinson symptoms caused by carbon monoxide poisoning or manganese intoxication.
GENERIC NAME: levetiracetamBRAND NAME: Keppra, Keppra XR
DRUG CLASS AND MECHANISM: Levetiracetam is an antiseizure (antiepileptic) drug. Its mechanism of action is unknown, but it inhibits the spread of seizure activity in the brain. In studies, addition of levetiracetam to other antiseizure drugs reduced the frequency of seizures more than placebo. The FDA approved levetiracetam in November 1999.
GENERIC AVAILABLE: Yes
PREPARATIONS: Tablets (immediate release): 250, 500, 750 and 1000 mg. Tablets (extended release): 500 and 750 mg. Oral solution: 100 mg/ml. Injection solution: 5, 10, 15, and 100 mg/ml.
STORAGE: Levetiracetam should be stored at 25 C (77 F). Brief storage at 15 C to 30 C (59 F to 86 F) is acceptable.
PRESCRIBED FOR: Levetiracetam is used in combination with other anti-seizure medications to treat myoclonic, partial onset, or tonic clonic seizures in children and adults.
DOSING: The recommended daily dose of levetiracetam in adults is 3000 mg. Therapy is initiated with 1000 mg daily (500 mg twice daily) and increased by 1000 mg/day every two weeks up to the maximum recommended dose of 3000 mg/day.
Immediate release tablets, oral solution, and intravenous solutions are administered twice daily, and extended release tablets are administered once daily.
The recommended daily dose for children is 60 mg/kg (30 mg/kg twice daily). Therapy is initiated with 20 mg/kg (10 mg/kg twice daily) and increased by 20 mg/kg every two weeks until the recommended daily dose of 60 mg/kg is reached.